Search Results

FIRST GENE THERAPY FOR A BLINDING EYE DISEASE RECEIVES FDA APPROVAL

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the...

THE VALUE OF IPSCS FOR STEM CELL THERAPY

Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field...

CLINICIAN-SCIENTIST EMERGING LEADER AWARD: DR. BRIAN BALLIOS

Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem cell therapies for people living with blindness and has a...

WILL GENE THERAPIES WIN THE RACE TO RESTORE SIGHT?

There is a lot of optimism for the potential to treat inherited eye diseases with gene therapy. Around the world, scientists are exploring ways to fix the genetic errors that lead to...

HOW CAN THE FBC HELP TO IMPROVE YOUR VISION HEALTH JOURNEY?

What is it like to live with a blinding eye disease in Canada? Do you have access to the vision care resources that you need? How can Fighting Blindness Canada (FBC) help...

ON THE ROAD TO PERSONALIZED THERAPIES FOR BLINDNESS: NEW STUDY REVEALS WHY GENETIC TESTING IS VITAL

Every day, my research is focused on developing an effective treatment for the blinding eye disease retinitis pigmentosa (RP). Recently, we made an alarming discovery: the SAME drug makes some genetic forms of...